Inflammatory Breast Cancer International Consortium | IBC-IC HomepageInflammatory Breast Cancer International Consortium | IBC-IC

Jose Rodrigo Espinosa Fernandez, MD

Clinician + Researcher

Title(s)

  • Professor, Medical Oncology Department
  • Professor, Medical Oncology Breast Cancer Unit
    Instituto Nacional de Cancerologia (INCAN), Mexico City, Mexico

Location(s)

  • Instituto Nacional de Cancerologia
  • Av. San Fernando 22 14080
  • Mexico City
  • Mexico
  • Phone: 5255 5628 0400

Research and Clinical Interests

IBC-Focused Research

I am a current clinician and researcher at NCI Mexico. My work has focused mainly in the execution of Phase III clinical studies for breast cancer. I have been working on the first IBC registry within the Mexican population.

During my clinical research fellowship under the mentorship of Naoto T. Ueno, MD, PhD, FACP, I was actively involved in breast cancer clinical research. My work focused on the design, development and execution of clinical studies, involving predictive and prognostic biomarkers in breast cancer (especially inflammatory and triple-negative breast cancer)—as well as the development of Phase I and Phase II clinical trials for the treatment of metastatic inflammatory breast cancer involving targeted therapy.

Clinical interests

  • Breast Cancer
  • Breast Cancer Clinical Research
  • Inflammatory Breast Cancer

Education and Board Certifications

MD

Universidad Autonoma de Guadalajara, Guadalajara, Mexico (2008)

Internship

Hospital Angeles del Carmen, Guadalajara, Mexico (2010)

Residency

Medical Oncology Instituto Nacional de Cancerologia (INCAN), Mexico City, Mexico (2016)

Fellowship

Breast Medical Oncology Clinical Research Fellowship, The University of Texas MD Anderson Cancer Center, Houston, Texas (2018)

Board Certification

Consejo Mexicano de Oncologia (CMO)

Year Began Practice

2018

Affiliations and Memberships

  • Instituto Nacional de Cancerologia (INCAN) Medical Society
  • Hospital Angeles Lomas Mexico Medical Society
  • American Society of Clinical Oncology (ASCO)
  • European Society for Medical Oncology (ESMO)

Recent Publications

Identification of triple-negative breast cancer cell lines classified under the same molecular subtype using different molecular characterization techniques: Implications for translational research
PLOS ONE; April 30, 2020

Real-World Outcomes Among Older Mexican Women with Breast Cancer Treated with Neoadjuvant Chemotherapy
Oncologist; April 10, 2020

Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer
Oncotarget; 2018

International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference.
Journal of Cancer; 2018

Combined pathologic-genomic algorithm for early-stage breast cancer improves cost-effective use of the 21-gene recurrence score assay
Annals of Oncology; May 1, 2018

Androgen receptor expression on circulating tumor cells in metastatic breast cancer
PLoS One; September 28, 2017

Clinical Trials

INCAN site for CHEKMATE 7FL clinical trial

INCAN IBC registry

View all clinical trials at clinicaltrials.gov >

Affiliated IBC-IC Center(s)

  • Instituto Nacional de Cancerologia (INCAN)
  • Mexico City
  • Research + Treatment Center

Join IBC-IC

Become part of our international consortium of researchers, clinicians, advocates and centers worldwide dedicated to ending IBC.

IBCIC.org makes every effort to keep researcher information as up-to-date as possible.
Contact this researcher to confirm any information regarding his or her profile.